FNCH News and Press, Finch Therapeutics Group Inc. From 12/01/23

2023-12-01 17:29:51 ET Gainers: Terns Pharmaceuticals ( TERN ) +10% . Alkermes  ( ALKS ) +9% . Forrester Research ( FORR ) +7% . Amkor Technology ( AMKR ) +5% . LifeMD ( LFMD ) +4% . Losers: James River Group Holding...

2023-12-01 09:59:03 ET More on Health Care Select Sector SPDR Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble Health Care Select Sector Fund ETF: Riding The Healthcare Boom For further details see: Redhill Biopha...

Finch Therapeutics Group Inc. (FNCH) is expected to report for Q3 2023

2023-06-13 10:10:06 ET Gainers: First Wave BioPharma ( FWBI ) +150% . YS Biopharma ( YS ) +20% . Akoya Biosciences ( AKYA ) +17% . Evoke Pharma ( EVOK ) +16% . Surmodics ( SRDX ) +16% . Losers: Jin Medical International ( ...

2023-06-13 08:20:35 ET Auddia ( AUUD ) -37% . Advanced Health Intelligence ( AHI ) -28% . Finch Therapeutics Group ( FNCH ) -22% . Asset Entities ( ASST ) -18% . Jin Medical International Ltd. ( ZJYL ) -16% on releasing new-generatio...

2023-06-12 17:14:04 ET Gainers: ARS Pharmaceuticals ( NASDAQ: SPRY ) +5% . Mersana Therapeutics ( MRSN ) +4% . Frontier Group  ( ULCC ) +2% . Sterling Infrastructure ( STRL ) +2% . Stitch Fix ( SFIX ) +2% . Losers:...

2023-06-09 07:11:38 ET Finch Therapeutics ( NASDAQ: FNCH ) will effect a one-for-30 reverse stock split of its issued and outstanding common stock, effective opening of trading on June 12, The reverse stock split is intended to increase the per share trading price of Finch...

BOSTON, June 09, 2023 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. (“Finch”, “Finch Therapeutics” or the “Company”) (Nasdaq: FNCH), a microbiome technology company with a portfolio of intellectual property and microbiome assets, today announced it w...

2023-05-10 13:37:04 ET Finch Therapeutics press release ( NASDAQ: FNCH ): Q1 GAAP EPS of -$1.33 misses by $1.24 . Revenue of $0.11M (-68.6% Y/Y). For further details see: Finch Therapeutics GAAP EPS of -$1.33 misses by $1.24, revenue of $0.11M

SOMERVILLE, Mass., May 10, 2023 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. (“Finch”, “Finch Therapeutics” or the “Company”) (Nasdaq: FNCH), a microbiome technology company with a portfolio of intellectual property and microbiome assets, today repo...